Expertise in
3
conditions

Jude A. Oben

London, ENG, GB 
Expertise in
3
conditions
London, ENG, GB 

Overview

Jude Oben practices practicing medicine in London, United Kingdom.

Mr. Oben is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Obesity, Familial Benign Copper Deficiency, and Metabolic Syndrome.

He is actively involved in clinical research, co-authoring 58 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

London, ENG, United Kingdom
Other Locations
Guy's And St Thomas' Hospital, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
View 1 Less Clinical Trial

58 Total Publications

Sour taste sensation as a neuroimmune modulator in liver injury.
Sour taste sensation as a neuroimmune modulator in liver injury.
Journal: Journal of hepatology
Published: May 22, 2025

Frequently Asked Questions about Jude A. Oben

Is Jude A. Oben a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Jude A. Oben is classified as an Advanced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jude A. Oben participate in research or clinical trials?

Yes. Jude A. Oben has published 58 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Jude A. Oben's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Oben's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile